SUBSCRIBE
SUBSCRIBE
News   Business

Maxygen, Inc. Reports Fourth Quarter and Year End 2008 Financial Results

February 11, 2009 | 
1 min read
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Maxygen, Inc. (Nasdaq:MAXY), a biotechnology company focused on the development of improved protein drugs, today announced financial and business results for the quarter and year ended December 31, 2008.
Earnings
MORE ON THIS TOPIC
Business people and concepts vector art exit
Cell therapy
Galapagos Exits Cell Therapy, Cuts 365 Employees
October 21, 2025
 · 
2 min read
Illustration showing hands holding arrow that goes up and down a few times and ends up in upward direction
Mergers & acquisitions
Rumors of Eli Lilly Buyout Send Nektar’s Shares Spiking
October 20, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Following Cancelled FDA Meeting, Kezar To Cut Employees, Eyes Strategic Alternatives
October 17, 2025
 · 
73 min read
 · 
BioSpace Editorial Staff
background, no people
Drug pricing
Novo, Lilly Shares Drop as Trump Promises $150 Ozempic
October 17, 2025
 · 
3 min read
 · 
Annalee Armstrong